Compare Bristol-Myers Squibb Co (BMY) vs Opendoor Technologies Inc (OPEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Opendoor Technologies Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.7 (market cap $129.94B), while Opendoor Technologies Inc trades at $3.57 (market cap $3.45B). The key difference: Bristol-Myers Squibb Co is far larger — about 37.7× Opendoor Technologies Inc's market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while Opendoor Technologies Inc pays none. Which is the better fit depends on your goals.
| BMY | OPEN | |
|---|---|---|
Market Cap | $129.94B | $3.45B |
Sector | Health | Real Estate |
52-Week High | $65.89 | $10.52 |
52-Week Low | $42.60 | $2.42 |
Enterprise Value | $163.92B | $4.52B |
Dividend Yield | 3.96% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Opendoor Technologies Inc
Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →
